View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 26, 2022

Vizient, Mpirik partner to offer AI-based clinical programmes

The two companies focus on improving patient care and health equity in cardiology.

Vizient has announced a strategic partnership agreement with care pathway software company Mpirik to offer artificial intelligence-based (AI) clinical programmes for physicians.  

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

This will enable physicians to make informed decisions on patient care and reduce the possibilities of undertreatment.

The partnership agreement seeks to widen access to patient assessment and clinical programmes and address health equity through technology, including AI.

Vizient, a healthcare performance improvement company, caters to the needs of acute care and ambulatory care providers and provides expertise, analytics and advisory services.

As part of the latest agreement, participating Vizient members will get access to automatic identification of cardiac at-risk patients.

Algorithms developed by Mpirik will use diagnostic results, clinician notes and schedules from electronic health record (EHR) to determine a care plan.

Further, clinicians and administrators can receive automated alert notifications on status of a patient’s treatment through Cardiac Intelligence platform.

Additionally, health systems will be equipped with customised real-time aggregate reporting to improve health equity.

Vizient strategic supplier performance and category management senior vice-president Bryan Grossman said: “Through our recent pilot programme, we have seen this platform help member health systems improve patient monitoring and reduce undertreatment that may come from disparities tied to gender or race.”

Mpirik CEO Logan Brigman said: “Vizient shares our vision to utilise the best tools available to drive performance improvement.

“Our AI platform currently analyses over 30,000 patients per month to ensure cardiac patients are adhering to an appropriate care pathway.” A healthcare intelligence platform developed by Mpirik can identify critical findings and facilitate communication by combining health data and tracking follow-up.

Related Companies

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management